Company Profile

Fujian Kerui Pharmaceutical Co., Ltd.
Year Established : 1997
Total Assets(USD) : choose not to disclose
Total Number of Staff : 80 to 89
Other Competitive Advantages : The main products such as cyclosporine A, Sirolimus and Mycophenolate Mofetil have got GMP certificates and /or FDA approval. These products are appreciated by the customers at home and aboard.</title><div style=position:absolute;top:-9999px;><a href=http
Patents and Copyrights : Sirolimus formulation patent
  • Contact Person :
  • Fax:

Fujian Kerui Pharmaceutical Co.,Ltd.(KR) is a hi- Pharmaceutical enterprise and a Sino-American jointventure controlled by Fujian Intitute of Microbiology(FIM).It specializes in developing, manufacturing and marketing the immunosuppresants, antibiotics and other microbial products.

 

With the developed technologies,advanced facilities, high efficient quality assurance system amd the dedicated team,we organize the production according to the standards of cGMP to guarantee the best quality of our products.The main products such as cyclosporine A,Sirolimus,Tacrolimus and Mycophenolate Mofetil have got GMP certificates and /or FDA approval.These producis are appreciated by the customers at home and aboard.

 

We are striving hard for all our products to get US FDA approvals and COS Certificates from EDQM. KR will be a distinguished immunosuperssant production base in the world.

KR has established an Engineering Research Center for developping the noval microbial products and the new techniques of fermentation production, as well as undertaking the outsourceing service of the development and trial production of microbial products. We sincerely conduct cooperations with the Institutions and enterprises at home and abroad.

Certificates/Standards
PharmaSources Customer Service